Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 08/12/2011
PIL Copegus 200mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 01/12/2011 and displayed until 08/12/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/11/2011 and displayed until 01/12/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 27/09/2011 and displayed until 28/11/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 07/01/2011 and displayed until 27/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 04/01/2010 and displayed until 07/01/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/07/2009 and displayed until 04/01/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 03/01/2008 and displayed until 15/07/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/09/2006 and displayed until 03/01/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 07/03/2006 and displayed until 21/09/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 25/01/2006 and displayed until 07/03/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/01/2006 and displayed until 25/01/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 23/01/2006 and displayed until 25/01/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 30/09/2005 and displayed until 23/01/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 27/09/2005 and displayed until 30/09/2005
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 27/09/2005 and displayed until 27/09/2005
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 28/11/2003 and displayed until 27/09/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 26/03/2003 and displayed until 28/11/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  ribavirin